Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
178 studies found for:    Open Studies | "Edema"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Edema" (178 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Condition: CYSTOID MACULAR EDEMA
Interventions: Drug: Ranibizumab,;   Drug: Triamcinolone acetonide
2 Not yet recruiting Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
Condition: Macular Edema
Intervention: Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
3 Recruiting A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema
Condition: Macular Edema
Interventions: Drug: Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321);   Drug: Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
4 Not yet recruiting Does NMES Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?
Condition: Oedema
Intervention: Device: Custom-built, two-channel stimulator
5 Not yet recruiting Effect of 80-mg Atorvastatin on Myocardial Edema
Condition: Myocardial Edema
Interventions: Drug: Atorvastatin 80mg;   Drug: Atorvastatin 10mg
6 Not yet recruiting Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema
Condition: Diabetic Macular Oedema
Intervention: Device: Ellex Integre NIR laser
7 Recruiting Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: aflibercept
8 Recruiting Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
Condition: Diabetic Macular Edema
Intervention: Drug: Triamcinolone Acetonide
9 Recruiting Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Ozurdex;   Drug: Lucentis
10 Not yet recruiting Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
Condition: Diabetic Macular Edema (DME)
Intervention: Drug: Aflibercept
11 Recruiting Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Ranibizumab
12 Recruiting Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
13 Not yet recruiting Unilateral Pulmonary Edema After Minimal-invasive Mitral Valve Surgery
Condition: Pulmonary Edema
Intervention:
14 Not yet recruiting Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study
Condition: Diabetic Macular Edema
Intervention: Biological: aflibercept
15 Recruiting Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
Condition: Inflammatory Macular Edema
Interventions: Drug: Dexamethasone;   Drug: Triamcinolone
16 Not yet recruiting Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: bevacizumab;   Device: PASCAL Endpoint Management (EpM) laser treatment
17 Recruiting Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema
Condition: CORNEAL EDEMA
Interventions: Device: Hyper-CL™ lens;   Device: Regular soft contact lens;   Drug: Salt solution
18 Recruiting Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
Condition: Macular Edema
Interventions: Drug: BI 1026706;   Drug: Placebo
19 Not yet recruiting AOI-Chronic Oedema Study
Condition: Lower Limb Chronic Oedema
Intervention: Other: Patients will undergo a lower limb MRI and blood tests
20 Recruiting Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.